Voyager Therapeutics (VYGR) Change in Acquisitions & Divestments (2015 - 2026)

Voyager Therapeutics has disclosed Change in Acquisitions & Divestments across 10 years of filings, most recently posting $51.6 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $51.6 million, down 56.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $302.9 million (up 5.78% YoY), and the FY2025 annual result was $262.0 million, down 30.02% from the prior year.
• Change in Acquisitions & Divestments came in at $51.6 million for Q1 2026 at Voyager Therapeutics, down from $118.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $118.8 million in Q1 2025 to a low of $51.6 million in Q1 2026.
• The 3-year median for Change in Acquisitions & Divestments is $109.9 million (2024), against an average of $93.4 million.
• Across the five-year window, Change in Acquisitions & Divestments advanced 8.06% in 2025 and slumped 56.6% in 2026, its largest moves.
• Voyager Therapeutics' Change in Acquisitions & Divestments stood at $109.9 million in 2024, then rose by 8.06% to $118.8 million in 2025, then plunged by 56.6% to $51.6 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $51.6 million (Q1 2026), $118.8 million (Q1 2025), and $109.9 million (Q1 2024), per Business Quant data.